Role of dyslipidemia in preeclamptic overweight pregnant women

Iranian Journal of Reproductive Medicine

Volumn 10, Issue 2, 2012, Pages 105-112

  Sharam, Seyede Hajar ^a   Tangestani, Azita ^a   Faraji, Roya ^a   Zahiri, Ziba ^a   Amiri, Azam ^a  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dyslipidemia; Overweight; Pre eclampsia

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; OBESITY; PREECLAMPSIA; PREGNANT WOMAN; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84857731085     PISSN: 16806433     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Roberts JM. Pregnancy-related hypertension. In: Creasy K, Resnik R, eds. Maternal-fetal medicine. Philadelphia, PA: W B Saunders Company, 1998: 833-872.
2. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after preeclampsia: population based cohort study. BMJ 2001; 323: 1213-1217.
3. Bodnar LM, Ness RB, Harger GF, Roberts JM. Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol 2005; 162: 1198-1206.
4. Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001; 357: 209-215.
5. Baksu B, Baksu A, Davas I, Akyol A, Gülbaba G. Lipoprotein (a) levels in women with pre-eclampsia and in normotensive pregnant women. J Obstet Gynaecol Res 2005; 31: 277-282.
6. Winkler K, Wetzka B, Hoffmann MM, Friedrich I, Kinner M, Baumstark MW, et al. Triglyceride-rich lipoproteins are associated with hypertension in preeclampsia. J Clin Endocrinol Metab 2003; 88: 1162-1166.
7. Enquobahrie DA, Williams MA, Butler CL, Frederick IO, Miller RS, Luthy DA. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 2004; 17: 574-581.
8. Ogura K, Miyatake T, Fukui O, Nakamura T, Kameda T, Yoshino G. Low-density lipoprotein particle diameter in normal pregnancy and preeclampsia. J Atheroscler Thromb 2002; 9: 42-47.
9. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
10. Winkler K, Wetzka B, Hoffmann MM, Friedrich I, Kinner M, Baumstark MW, et al. Triglyceride-rich lipoproteins are associated with hypertension in preeclampsia. J Clin Endocrinol Metab 2003; 88: 1162-1166.
11. Akhavan S, Modarres Gilani M, Borna S, Shahghaibi S, Yousefinejad V, Shahsavari S. Maternal plasma lipid concentrations in first trimester of pregnancy and risk of severe preeclapmsia. Pak J Med Sci 2009; 25: 563-567.
12. Baker AM, Klein RL, Moss KL, Haeri S, Boggess K. Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia. Am J Obstet Gynecol 2009; 201: 293.e1-4.
13. Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 1997; 89: 403-408.
14. th Ed. Connecticut: Appletton and Lange 1997; 693-744.
15. Clausen T, Djurovic S, Henriksen T. Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. BJOG 2001; 108: 1081-1087.
16. Walsh SW. Obesity: a risk factor for preeclampsia. Trends Endocrinol Metab 2007; 18: 365-370.
17. Sattar N, Greer IA, Louden J, Lindsay G, McConnell M, Shepherd J, et al. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J Clin Endocrinol Metab 1997; 82: 2483-2491.
18. Lorentzen B, Henriksen T. Plasma lipids and vascular dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16: 33-39.
19. Couillard C, Ruel G, Archer WR, Pomerleau S, Bergeron J, Couture P, et al. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab 2005; 90: 6454-6459.
20. de Man FH, Weverling-Rijnsburger AW, van der Laarse A, Smelt AH, Jukema JW, Blauw GJ. Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin. Arterioscler Thromb Vasc Biol 2000; 20: 744-750.
21. Hayman R, Brockelsby J, Kenny L, Baker P. Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor. J Soc Gynecol Investig 1999; 6: 3-10.
22. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002; 325: 157-160.
23. Belogolovkin V, Eddleman KA, Malone FD, Sullivan L, Ball RH, Nyberg DA, et al. The effect of low body mass index on the development of gestational hypertension and preeclampsia. J Matern Fetal Neonatal Med 2007; 20: 509-513.
24. Xiao R, Sorensen TK, Williams MA, Luthy DA. Influence of pre-eclampsia on fetal growth. J Matern Fetal Neonatal Med 2003; 13: 157-162.
25. Stone JL, Lockwood CJ, Berkowitz GS, Alvarez M, Lapinski R, Berkowitz RL. Risk factors for severee preeclampsia. Obstet Gynecol 1994; 83: 357-361.